Zabal C, García MJA, Calderón CJ, Patiño BE, Buendía HA, Attie F

Language: Spanish
References: 9
Page: 327-334
PDF size: 152.87 Kb.

ABSTRACT

Object: To report the immediate and mid-term follow-up results of the Amplatzer® membranous VSD occluder for the percutaneous occlusion of the perimembranous VSD. Background: Percutaneous perimembranous VSD occlusion is still considered an experimental method where a variety of devices have been tested. Nowadays, more than 500 membranous Amplatzer®.devices have been implanted worldwide with encouraging results. Method: We included 6 patients (1 man and 5 women) with a mean age of 9.9 years (range, 3 to 17.5) in whom percutaneous perimembranous VSD closure was attempted. Results: In one of the patients, positioning of the device was not possible (intention to treat success rate, 83.3%). In the remaining five patients, there was a single defect. The VSD mean diameter with echo was 7 ± 1.7 mm (range, 5.1 to 9) and with angio was 6.9 ± 1 (range, 6 to 8). Mean pulmonary pressure was 20.2 ± 7.7 mm Hg (range, 12-30) and Qp/Qs was 1.69 ± 0.65 (range, 1.2-2.8). A single device was use in all cases. Immediate angiographic control showed complete occlusion in two patients, trivial shunt in one, and mild shunt in two. Follow-up was at least 4 months. Only one patient has residual trivial shunt, the rest of the defects are completely closed. Conclusion: The special design of the Amplatzer® membranous VSD occluder allows percutaneous closure of this defect in a safe and effective way, with good mid-term results. In selected cases, this is a good alternative to surgery in the treatmen of this cardiac defect.

REFERENCES

1. Attie F: Comunicación Interventricular. En: Attie F, Zabal C, Buendía A. Cardiología Pediátrica. Diagnóstico y Tratamiento. Editorial Médica Panamericana. México. 1993: 155-169.

2. McDaniel NL, Gutgesell HP: Ventricular Septal Defects. En: Allen HD, Gutgesell HP, Clark EB, Driscoll DJ: Moss and Adams’ Heart Disease in Infants, Children, and Adolescents. Philadelphia. Lippincott Williams & Wilkins. 2001: 636-651.

3. Kirklin JW, Barratt-Boyes G: Ventricular Septal Defect. En: Kirklin JW, Barratt-Boyes G: Cardiac Surgery. Second Edition. Nueva York. Churchill Livingstone. 1993: 749-824.

4. Backer CL, Winters RC, Zales VR, Takami H, Muster AJ, Benson DW Jr, Mavroudis C: The restrictive ventricular septal defect: how small is too small to close? Ann Thorac Surg 1993; 56: 1014-1018.

5. Zabal C: El cateterismo intervencionista en las cardiopatías congénitas. Arch Cardiol Mex 2001; 71 (Supl 1): S188-S191.

6. Hijazi ZM, Hakim F, Haweleh AA, Madani A, Tarawna W, Hiari A, Cao QL: Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience. Catheter Cardiovasc Interv 2002; 56: 508-515 .

7. Bass JL, Kalra GS, Arora R, Masura J, Gavora P, Thanopoulos BD, et al: Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv 2003; 58: 238-245 .

8. Pedra CA, Pedra SR, Esteves CA, Chamie F, Christiani LA, Fontes VF: Transcatheter closure of perimembranous ventricular septal defects. Expert Rev Cardiovasc Ther 2004; 2: 253-264.

9. Pawelec-Wojtalik M, Masura J, Siwinska A, Wojtalik M, Smoczyk W, Gorzna-Kaminska H, Surmacz R: Transcatheter closure of perimembranous ventricular septal defect using an Amplatzer occluder - early results. Kardiol Pol 2004; 61: 31-40.